Clinical Trials Logo

Filter by:
NCT ID: NCT04279418 Completed - Alzheimer Disease Clinical Trials

Non-pharmacological Intervention for Preclinical Alzheimer's Disease

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD) is the most common form of neurodegenerative disorders leading to dementia. Currently, there has been no effective drugs targeting this disease. Functional food is considered as a potentially non-pharmacologic treatment. In this project, the investigators aim to investigate the effectiveness of a mixed functional food with main compositions of ginsenoside, green tea polyphenols and marine collagen peptide on cognition for individuals with subjective cognitive decline (SCD). Taking the randomized, double-blind, placebo-controlled method, participants in the functional food group will take mixed functional foods for three months and those in the placebo group will take placebo. After that, the investigators will investigate the changes of cognitive function. Furthermore, based on the neuroimaging technique, the regulatory mechanism of functional food in intervening SCD will be revealed from the perspective of altered brain functional activity. In conclusion, these results are beneficial for understanding the therapeutic effect of mixed functional foods as a non-drug treatment for early AD and further elucidating the potential brain mechanism, which are of great values in solving scientific and clinical practice issues.

NCT ID: NCT04292158 Completed - Early Warning Score Clinical Trials

The New Golden Standard: the Early Warning Score Algorithm

EAGLE
Start date: April 1, 2019
Phase:
Study type: Observational

The objective is this study is the development and implementation of a smart algorithm to compute an early warning indicator able to predict early patient deterioration.

NCT ID: NCT04300933 Completed - Alzheimer Disease Clinical Trials

Neurofeedback Intervention for Preclinical Alzheimer's Disease

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD) is the most common form of neurodegenerative disorders leading to dementia. Currently, there has been no effective pharmacologic therapy for this disease. Electroencephalogram-based neurofeedback is considered as a potentially treatment strategy. In this project, the investigators aim to investigate the effectiveness of neurofeedback therapy on cognition for individuals with subjective cognitive decline (SCD). Participants will receive electroencephalogram-based neurofeedback therapy once a day for successive five days. Then, the investigators will evaluate the changes of memory function between baseline and post-therapy visits.

NCT ID: NCT04310878 Completed - Clinical trials for Surgical Site Infection

Gaps Between Evidence and Practice in Prevention of Surgical Site Infection in Spain

SurveyOIC
Start date: April 1, 2019
Phase:
Study type: Observational

Web-based survey to members of 10 Spanish Associations of surgical nurses and surgeons of different specialities to know the application of preventative measures for surgical site infection.

NCT ID: NCT04315740 Completed - Asthma Clinical Trials

Acute Health Effects Due to Ultrafine Particles From Candles and Cooking

Ultrafine
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

People spend up to 90% of their life indoor, and the way we live and behave in our homes has substantial effects on our health and well-being. Particle contamination is suggested to have substantial negative effects on health, with candles and cooking emitting the largest amount of particles, thus being the largest contributors to indoor air pollution. The overall aim of the present project is to contribute to increased understanding of the association between indoor particulate air pollution and health and well-being.

NCT ID: NCT04324216 Completed - Mental Health Clinical Trials

Three-dimensional Virtual Reality and Hands-on Aromatherapy

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

A quasi-experimental trial was designed to evaluate the effectiveness of this combination in promoting happiness, perceived stress, sleep quality, experience on meditation, and life satisfaction among institutionalized older adults in Taiwan.

NCT ID: NCT04337268 Completed - Clinical trials for The GLP-1-mediated Gut-kidney Axis

Acute Effects of GLP-1 on Renal Hemodynamics

GLP1RRBF
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This study investigates the hypothesis, that GLP-1's suppression of ANG II and natriuretic action increase medullary perfusion and decrease oxygen consumption, leading to higher tissue oxygenation.

NCT ID: NCT04341649 Completed - Clinical trials for Vagus Nerve Stimulation

Multi-device Testing for Autonomic Nervous System Stimulation

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The Vagus nerve (VN) serve as an "unconscious inner brain" that integrates messages from the body and provides metabolic homeostatic regulation to various organs.In this study the investigators want to compare different ways to stimulate the vagus nerve to assess their respective effects compared to a sham stimulation. Each participant will be exposed in a random way to 7 different ways to stimulate the VN: - Manual Head Massage - Mechanical Head Massager (BREO Inc. Helmet) - Low laser Therapy (LLT) - Sham LLT - Transcutaneous Electrical Nervous Stimulation (TENS) ear stimulation (as testing phase prototype device) - Deep and slow breathing (as testing intervention based on video app) - Relaxed reading time (as control situation) Therefore, within the same design the investigators want to conduct two separate studies that should lead to two separate publications: - Study 1: comparison of manual head massage to mechanical Helmet massager and relaxed reading - Study 2: comparison of LLT with sham LLT and relaxed reading The two other interventions: TENS ear stimulation and Deep and Slow breathing are purely observational to gain knowledge in context of a convenient design.

NCT ID: NCT04351126 Completed - Clinical trials for Ovarian Hyperstimulation Syndrome

Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

Start date: April 1, 2019
Phase: Phase 2
Study type: Interventional

lines of evidence that support nature of ovarian hyperstimulation syndrome (OHSS) as "defective mineralocorticoid response" are cited, our hypothesis is tested clinically in both prophylaxis against and treatment of OHSS.

NCT ID: NCT04355715 Completed - SARS-Cov-2 Clinical Trials

Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia

COVID-Scan
Start date: April 1, 2019
Phase:
Study type: Observational

This research aims to improve the screening for COVID-19 upon admission to the Montpellier University Hospital for an act under general anesthesia or at high risk of transmission of the virus. Indeed, routine nasal swabs present many false negatives (60 to 70%) and many patients with the coronavirus have little or no symptoms. Performing a chest CT scan can reveal early signs very suggestive of viral pneumoniae due to the new coronavirus without additional risk compared to a simple chest X-ray (no injection of contrast medium, low exposure). The objective is to assess the sensitivity of the diagnosis of COVID-19 by carrying out a nasopharyngeal RT-PCR and a low dose thoracic scanography at the hospital admission of patients scheduled to a procedure under general anesthesia or at risk of aerosolization (surgery, endoscopy, procedures involving risk of interventional radiology) in order to limit the risks of transmission to healthcare professionals or other patients and to rationalize the use of protective equipment. This is an observational research without modification of care in the setting of COVID-19 pandemia. All clinical and biological data will be issued from routine care and medical charts. Routine use of CT scan and nasal swabs is an institutional approved strategy. Serologic tests will be performed as soon as available from serum collection collected after routine blood analysis. All data will be anonymously recorded after information and non-opposition of the patient.